Form 8-K - Current report:
SEC Accession No. 0001104659-14-075993
Filing Date
2014-11-03
Accepted
2014-11-03 16:29:45
Documents
10
Period of Report
2014-11-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-23554_18k.htm 8-K 37221
2 EX-4.1 a14-23554_1ex4d1.htm EX-4.1 781138
3 EX-4.2 a14-23554_1ex4d2.htm EX-4.2 108477
4 EX-99.1 a14-23554_1ex99d1.htm EX-99.1 9971
5 GRAPHIC g235541kg15i001.jpg GRAPHIC 2508
6 GRAPHIC g235541kg13i001.jpg GRAPHIC 1631
7 GRAPHIC g235541kg13i002.jpg GRAPHIC 2014
8 GRAPHIC g235541kg13i003.jpg GRAPHIC 2008
9 GRAPHIC g235541kg13i004.jpg GRAPHIC 2156
10 GRAPHIC g235541kg13i005.jpg GRAPHIC 1847
  Complete submission text file 0001104659-14-075993.txt   956055
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

EIN.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35268 | Film No.: 141189809
SIC: 2834 Pharmaceutical Preparations